GAIN THERAPEUTICS INC (GANX) Institutional Ownership Changes & 13F Activity
GAIN THERAPEUTICS INC (GANX). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q4 2025). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Marshall Wace, Llp, Jones Financial Companies Lllp, Susquehanna International Group, Llp, Greenlight Capital, and Jane Street Group, Llc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Newedge Advisors, Llc | Buy | +10,600 | — | 10,600 | $34.13K | Q4 2025 | Feb 18, 2026 |
| Jones Financial Companies Lllp | Buy | +702,213 | — | 702,213 | $2.26M | Q4 2025 | Feb 17, 2026 |
| Susquehanna International Group, Llp | Buy | +684,349 | — | 684,349 | $2.20M | Q4 2025 | Feb 17, 2026 |
| Greenlight Capital | Buy | +566,130 | — | 566,130 | $1.82M | Q4 2025 | Feb 17, 2026 |
| Cresset Asset Management, Llc | Buy | +160,000 | — | 160,000 | $515.20K | Q4 2025 | Feb 17, 2026 |
| Northern Trust Corp | Buy | +102,001 | — | 102,001 | $328.44K | Q4 2025 | Feb 17, 2026 |
| Prelude Capital Management, Llc | Buy | +35,820 | — | 35,820 | $115.34K | Q4 2025 | Feb 17, 2026 |
| Point72 Asset Management, L.P. | Buy | +32,480 | — | 32,480 | $104.59K | Q4 2025 | Feb 17, 2026 |
| Bridgeway Capital Management, Llc | Buy | +30,004 | — | 30,004 | $96.61K | Q4 2025 | Feb 17, 2026 |
| Lighthouse Investment Partners, Llc | Buy | +23,040 | — | 23,040 | $74.19K | Q4 2025 | Feb 17, 2026 |
| Engineers Gate Manager Lp | Buy | +14,617 | — | 14,617 | $47.07K | Q4 2025 | Feb 17, 2026 |
| Millennium Management Llc | Buy | +14,002 | — | 14,002 | $45.09K | Q4 2025 | Feb 17, 2026 |
| Tower Research Capital Llc (Trc) | Buy | +6,859 | — | 6,859 | $22.09K | Q4 2025 | Feb 17, 2026 |
| Bank Of America Corp | Buy | +3,908 | — | 3,908 | $12.58K | Q4 2025 | Feb 17, 2026 |
| Marshall Wace, Llp | Buy | +1,662,293 | — | 1,662,293 | $5.35M | Q4 2025 | Feb 13, 2026 |
| State Street Corp | Buy | +157,537 | — | 157,537 | $507.27K | Q4 2025 | Feb 13, 2026 |
| Morgan Stanley | Buy | +147,591 | — | 147,591 | $475.24K | Q4 2025 | Feb 13, 2026 |
| Focus Partners Wealth | Buy | +77,855 | — | 77,855 | $250.69K | Q4 2025 | Feb 13, 2026 |
| Omers Administration Corp | Buy | +37,300 | — | 37,300 | $120.11K | Q4 2025 | Feb 13, 2026 |
| Wealthspire Advisors, Llc | Buy | +16,900 | — | 16,900 | $54.42K | Q4 2025 | Feb 13, 2026 |
| Kestra Advisory Services, Llc | Buy | +12,000 | — | 12,000 | $38.64K | Q4 2025 | Feb 13, 2026 |
| Mai Capital Management | Buy | +4,410 | — | 4,410 | $14.20K | Q4 2025 | Feb 13, 2026 |
| Wells Fargo & Company/Mn | Buy | +2,650 | — | 2,650 | $8.53K | Q4 2025 | Feb 13, 2026 |
| Jane Street Group, Llc | Buy | +242,328 | — | 242,328 | $780.30K | Q4 2025 | Feb 12, 2026 |
| Blackrock, Inc. | Buy | +209,579 | — | 209,579 | $674.84K | Q4 2025 | Feb 12, 2026 |
| Renaissance Technologies LLC | Sell | -108,700 | -86.2% | 17,400 | $56.03K | Q4 2025 | Feb 12, 2026 |
| Hrt Financial Lp | Buy | +55,679 | — | 55,679 | $179.00K | Q4 2025 | Feb 12, 2026 |
| Group One Trading Llc | Buy | +54,159 | — | 54,159 | $174.39K | Q4 2025 | Feb 12, 2026 |
| Sandhill Capital Partners Llc | Buy | +15,400 | — | 15,400 | $49.59K | Q4 2025 | Feb 12, 2026 |
| Commonwealth Equity Services, Llc | Buy | +12,685 | — | 12,685 | $40.85K | Q4 2025 | Feb 12, 2026 |
Frequently asked questions about GANX activity
Which institutional owners are buying GANX?
Institutional owners buying GANX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in GANX activity?
"Buy" means an investor increased their reported position in GANX compared to the prior reporting period. This reflects growing exposure to GAIN THERAPEUTICS INC (GANX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in GANX increasing?
Institutional interest in GANX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related GANX Institutional Insights
- GANX Overview
- GANX 13F Institutional Holders
- GANX Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- GANX Insider Trading & SEC Form 4 Activity
- GANX Articles
- Top Institutional Investor Stock Rankings